A randomized controlled trial of an Internet-based intervention for eating disorders and the added value of expert-patient support: study protocol.
Cost-effectiveness
E-mental health
Eating disorders
Expert patient
Internet
Internet-based
Intervention
Peer support
Prevention
Treatment
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
16 Aug 2019
16 Aug 2019
Historique:
received:
31
10
2018
accepted:
12
07
2019
entrez:
18
8
2019
pubmed:
20
8
2019
medline:
11
2
2020
Statut:
epublish
Résumé
E-mental health has become increasingly popular in interventions for individuals with eating disorders (EDs). It has the potential to offer low-threshold interventions and guide individuals to the needed care more promptly. Featback is such an Internet-based intervention and consists of psychoeducation and a fully automated monitoring and feedback system. Preliminary findings suggest Featback to be (cost-)effective in reducing ED symptomatology. Additionally, e-mail or chat support by a psychologist did not enhance the effectiveness of Featback. Support by an expert patient (someone with a lived experience of an ED) might be more effective, since that person can effectively model healthy behavior and enhance self-efficacy in individuals struggling with an ED. The present study aims to replicate and build on earlier findings by further investigating the (cost-)effectiveness of Featback and the added value of expert-patient support. The study will be a randomized controlled trial with a two-by-two factorial design with repeated measures. The four conditions will be (1) Featback, in which participants receive automated feedback on a short monitoring questionnaire weekly, (2) Featback with weekly e-mail or chat support from an expert patient, (3) weekly support from an expert patient, and (4) a waiting list. Participants who are 16 years or older and have at least mild self-reported ED symptoms receive a baseline measure. Subsequently, they are randomized to one of the four conditions for 8 weeks. Participants will be assessed again post-intervention and at 3, 6, 9, and 12 months follow-up. The primary outcome measure will be ED psychopathology. Secondary outcome measures are experienced social support, self-efficacy, symptoms of anxiety and depression, user satisfaction, intervention usage, and help-seeking attitudes and behaviors. The current study is the first to investigate e-mental health in combination with expert-patient support for EDs and will add to the optimization of the delivery of Internet-based interventions and expert-patient support. Netherlands Trial Register, NTR7065 . Registered on 7 June 2018.
Sections du résumé
BACKGROUND
BACKGROUND
E-mental health has become increasingly popular in interventions for individuals with eating disorders (EDs). It has the potential to offer low-threshold interventions and guide individuals to the needed care more promptly. Featback is such an Internet-based intervention and consists of psychoeducation and a fully automated monitoring and feedback system. Preliminary findings suggest Featback to be (cost-)effective in reducing ED symptomatology. Additionally, e-mail or chat support by a psychologist did not enhance the effectiveness of Featback. Support by an expert patient (someone with a lived experience of an ED) might be more effective, since that person can effectively model healthy behavior and enhance self-efficacy in individuals struggling with an ED. The present study aims to replicate and build on earlier findings by further investigating the (cost-)effectiveness of Featback and the added value of expert-patient support.
METHODS
METHODS
The study will be a randomized controlled trial with a two-by-two factorial design with repeated measures. The four conditions will be (1) Featback, in which participants receive automated feedback on a short monitoring questionnaire weekly, (2) Featback with weekly e-mail or chat support from an expert patient, (3) weekly support from an expert patient, and (4) a waiting list. Participants who are 16 years or older and have at least mild self-reported ED symptoms receive a baseline measure. Subsequently, they are randomized to one of the four conditions for 8 weeks. Participants will be assessed again post-intervention and at 3, 6, 9, and 12 months follow-up. The primary outcome measure will be ED psychopathology. Secondary outcome measures are experienced social support, self-efficacy, symptoms of anxiety and depression, user satisfaction, intervention usage, and help-seeking attitudes and behaviors.
DISCUSSION
CONCLUSIONS
The current study is the first to investigate e-mental health in combination with expert-patient support for EDs and will add to the optimization of the delivery of Internet-based interventions and expert-patient support.
TRIAL REGISTRATION
BACKGROUND
Netherlands Trial Register, NTR7065 . Registered on 7 June 2018.
Identifiants
pubmed: 31420063
doi: 10.1186/s13063-019-3574-2
pii: 10.1186/s13063-019-3574-2
pmc: PMC6697984
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
509Subventions
Organisme : ZonMw
ID : 636310001
Références
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Health Econ. 1995 Jun;14(2):171-89
pubmed: 10154656
Psychol Methods. 2002 Jun;7(2):147-77
pubmed: 12090408
Int J Nurs Stud. 2003 Mar;40(3):321-32
pubmed: 12605954
J Abnorm Soc Psychol. 1961 May;62:713-5
pubmed: 13875334
Int J Eat Disord. 2004 Nov;36(3):280-95
pubmed: 15478137
Br J Gen Pract. 2005 Nov;55(520):831-7
pubmed: 16281998
Int J Eat Disord. 2006 Dec;39(8):667-76
pubmed: 16868992
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005108
pubmed: 17943839
Int J Eat Disord. 2008 May;41(4):368-71
pubmed: 18306345
J Epidemiol Community Health. 2008 Apr;62(4):361-7
pubmed: 18339831
Med J Aust. 2008 Nov 17;189(10 Suppl):S21-4
pubmed: 19143586
Health Expect. 2009 Dec;12(4):396-406
pubmed: 19691464
Int J Eat Disord. 2010 Nov 1;43(7):633-47
pubmed: 19806607
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Eval Health Prof. 2010 Mar;33(1):56-80
pubmed: 20164106
Int J Eat Disord. 2010 Apr;43(3):195-204
pubmed: 20186717
Int J Behav Nutr Phys Act. 2010 May 11;7:36
pubmed: 20459779
Gen Hosp Psychiatry. 2011 Jan-Feb;33(1):29-36
pubmed: 21353125
Eat Weight Disord. 2010 Dec;15(4):e234-9
pubmed: 21406946
Clin Psychol Rev. 2011 Jul;31(5):727-35
pubmed: 21501580
Qual Life Res. 2012 Feb;21(1):167-76
pubmed: 21598064
Clin Pract Epidemiol Ment Health. 2011;7:74-83
pubmed: 21687562
Am J Orthopsychiatry. 2011 Jul;81(3):351-9
pubmed: 21729015
Int J Eat Disord. 2012 Apr;45(3):428-38
pubmed: 21744375
Eur Eat Disord Rev. 2012 Jan;20(1):1-8
pubmed: 21796737
Psychol Assess. 2012 Sep;24(3):565-72
pubmed: 22082035
Health Psychol. 2014 Jan;33(1):52-65
pubmed: 22924446
Hum Nat. 2013 Sep;24(3):336-47
pubmed: 23881574
Curr Opin Psychiatry. 2013 Nov;26(6):543-8
pubmed: 24060914
Trials. 2013 Oct 17;14:340
pubmed: 24135131
Health Econ. 2015 Mar;24(3):258-69
pubmed: 24254584
PLoS One. 2013 Dec 19;8(12):e85287
pubmed: 24367708
BMC Psychiatry. 2014 Feb 14;14:39
pubmed: 24528545
J Eat Disord. 2014 Aug 22;2(1):24
pubmed: 25426293
Behav Res Ther. 2014 Dec;63:122-31
pubmed: 25461787
Am J Community Psychol. 2015 Jun;55(3-4):455-71
pubmed: 25861883
Trials. 2015 Apr 16;16:165
pubmed: 25885697
Int J Eat Disord. 2015 Sep;48(6):775-8
pubmed: 26052695
PLoS One. 2015 Jun 08;10(6):e0129688
pubmed: 26053921
Int J Eat Disord. 2016 Jan;49(1):19-31
pubmed: 26607683
Value Health. 2015 Dec;18(8):994-9
pubmed: 26686783
Eat Behav. 2016 Apr;21:66-75
pubmed: 26761787
J Ment Health. 2016 Oct;25(5):441-447
pubmed: 26850624
Curr Psychiatry Rep. 2016 Apr;18(4):42
pubmed: 26946513
J Med Internet Res. 2016 Jun 17;18(6):e159
pubmed: 27317358
Value Health. 2016 Jun;19(4):343-52
pubmed: 27325326
Int J Eat Disord. 2016 Dec;49(12):1068-1076
pubmed: 27441418
BMC Public Health. 2016 Aug 24;16(1):864
pubmed: 27558630
Pharmacoeconomics. 2016 Nov;34(11):1071-1074
pubmed: 27613159
Behav Res Ther. 2017 Feb;89:66-74
pubmed: 27907817
BMC Psychiatry. 2017 Feb 2;17(1):46
pubmed: 28148234
Eur Psychiatry. 2017 May;42:103-110
pubmed: 28364685
Cochrane Database Syst Rev. 2017 Apr 19;4:CD012331
pubmed: 28421600
J Consult Clin Psychol. 2017 Sep;85(9):883-895
pubmed: 28425735
Pain. 2017 Aug;158(8):1437-1445
pubmed: 28644822
Behav Res Methods. 2018 Oct;50(5):2016-2034
pubmed: 29071652
Int J Eat Disord. 2017 Dec;50(12):1378-1384
pubmed: 29076172
PLoS One. 2017 Nov 9;12(11):e0187477
pubmed: 29121647
BMC Res Notes. 2017 Dec 07;10(1):709
pubmed: 29212554
Pilot Feasibility Stud. 2018 Apr 18;4:75
pubmed: 29750119
Eat Disord. 2018 Nov-Dec;26(6):556-574
pubmed: 30222057
Int J Eat Disord. 1994 Nov;16(3):227-38
pubmed: 7833956
Int J Eat Disord. 1994 Dec;16(4):363-70
pubmed: 7866415
Tijdschr Gerontol Geriatr. 1994 Oct;25(5):192-6
pubmed: 7974641
Int J Eat Disord. 1993 May;13(4):369-84
pubmed: 8490639